2011
DOI: 10.1007/bf03346693
|View full text |Cite
|
Sign up to set email alerts
|

Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty

Abstract: The different response of allopregnanolone to GnRH and GnRH agonist analog might reflect the agonist and antagonist action exerted by these secretagogues. Our data suggest the prevalent gonadal allopregnanolone production in CPP subjects and the usefulness of its measurement in the diagnosis of CPP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 37 publications
0
5
0
Order By: Relevance
“…To our knowledge, up to now, two studies have reported data on the HPO response to subcutaneous Triptorelin acetate in girls with precocious sexual development. 18,20 Only one of them 18 was focused on Triptorelin test as a method to diagnose CPP. However, this study was retrospective, no GnRH test as reference standard was used and no E 2 response was assessed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To our knowledge, up to now, two studies have reported data on the HPO response to subcutaneous Triptorelin acetate in girls with precocious sexual development. 18,20 Only one of them 18 was focused on Triptorelin test as a method to diagnose CPP. However, this study was retrospective, no GnRH test as reference standard was used and no E 2 response was assessed.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, up to now, two studies have reported data on the HPO response to subcutaneous Triptorelin acetate in girls with precocious sexual development . Only one of them was focused on Triptorelin test as a method to diagnose CPP.…”
Section: Discussionmentioning
confidence: 99%
“…Following overnight fasting, the participants were told to arrive at the hospital at approximately 8:00 am. Four to five milliliters of blood were collected (0-min sample), and then the LHRH was injected as an intravenous bolus of 2.5 μg/kg (maximum dose < 100 μg) ( 27 ) via an indwelling catheter. At 30 and 60 min after injection, 2 ml of blood were drawn again.…”
Section: Methodsmentioning
confidence: 99%
“…Following overnight fasting, the participants were asked to arrive at the hospital at approximately 8:00 am. LHRH was injected as an intravenous bolus of 2.5 μg/kg (maximum dose < 100 μg) (25) through an indwelling catheter. Four to five milliliters of blood were collected immediately before injection (0-min sample), and then 2 ml were collected at 30 and 60 min after the injection.…”
Section: Methodsmentioning
confidence: 99%